Tumour necrosis factor-alpha (TNF-alpha) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions.
about
A phase two randomised controlled double blind trial of high dose intravenous methylprednisolone and oral prednisolone versus intravenous normal saline and oral prednisolone in individuals with leprosy type 1 reactions and/or nerve function impairmeExpression of Toll-like receptor 2 on human Schwann cells: a mechanism of nerve damage in leprosy.Effects of thalidomide on intracellular Mycobacterium leprae in normal and activated macrophages.Leprosy: pathogenesis updated.In Situ complement activation and T-cell immunity in leprosy spectrum: An immunohistological study on leprosy lesional skinCortisol metabolism, cortisol sensitivity and the pathogenesis of leprosy reactions.Granulomatous reactivation during the course of a leprosy infection: reaction or relapse.Analysis of antibody and cytokine markers for leprosy nerve damage and reactions in the INFIR cohort in India.Soluble tumor necrosis factor alpha receptors in sera from leprosy patients.Novel mechanisms in the immunopathogenesis of leprosy nerve damage: the role of Schwann cells, T cells and Mycobacterium leprae.Reactions following completion of 1 and 2 year multidrug therapy (MDT).Cytokine and protein markers of leprosy reactions in skin and nerves: baseline results for the North Indian INFIR cohort.The armadillo as a model for peripheral neuropathy in leprosy.Mycobacterium leprae and leprosy: a compendium.Gene set signature of reversal reaction type I in leprosy patients.Genetics of susceptibility to leprosy.Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview.Leprosy: an overview of pathophysiologyClinically unsuspected neuritic leprosy with caseation necrosis.Understanding the type 1 reactional state for early diagnosis and treatment: a way to avoid disability in leprosy.Effects of prednisolone treatment on cytokine expression in patients with leprosy type 1 reactions.Immunocytochemical localization of inducible nitric oxide synthase and transforming growth factor-beta (TGF-beta) in leprosy lesions.Immunohistochemical analysis of cellular infiltrate and gamma interferon, interleukin-12, and inducible nitric oxide synthase expression in leprosy type 1 (reversal) reactions before and during prednisolone treatment.The effect of systemic corticosteroid therapy on the expression of toll-like receptor 2 and toll-like receptor 4 in the cutaneous lesions of leprosy Type 1 reactions.Production of tumor necrosis factor and nitric oxide by macrophages infected with live and dead mycobacteria and their suppression by an interleukin-10-secreting recombinant.Granuloma necrosis during Mycobacterium avium infection does not require tumor necrosis factor.IgG1 antimycobacterial antibodies can reverse the inhibitory effect of pentoxifylline on tumour necrosis factor alpha (TNF-alpha) secreted by mycobacterial antigen-stimulated adherent cells.Increased Langerhans cell accumulation after mycobacterial stimuli.Effectiveness of 32 versus 20 weeks of prednisolone in leprosy patients with recent nerve function impairment: A randomized controlled trial.Expression of inducible nitric oxide synthase and nitrotyrosine in borderline leprosy lesions.Induction of apoptosis in monocytes by Mycobacterium leprae in vitro: a possible role for tumour necrosis factor-alpha.Effect of thalidomide on the expression of TNF-alpha m-RNA and synthesis of TNF-alpha in cells from leprosy patients with reversal reaction.Extensive Lepromatous Lymphadenitis Preceding Lesions on the Face and Earlobes: An Unusual Presentation of Leprosy in Singapore.
P2860
Q28477712-72FB9F8E-11C8-4C89-B750-D1AF80CE04A3Q30531768-0544C6E6-CF78-4E4A-B06F-F957AC5A9FE9Q33594060-55D5AEEA-36DB-4CDC-BDFE-F54431EB9564Q33659298-9D964D43-79BD-48DB-A8A7-1A3B354AEBFBQ33688349-D55C943F-29C2-4D10-A1A8-EFB3E9DCFB72Q33724506-11034D6A-3B65-4ED7-B448-039CC4BA12C7Q33784156-B2E624A1-1C30-40D6-B5E3-E21DD95D460FQ33847430-C258F826-3D79-4E02-AFF9-5441D66089C6Q34000080-A0DAE5FE-43FD-40DC-BDDD-035E012AF7E5Q34007445-71FA9118-06C3-438A-BCD3-3D361E860FA9Q34087450-216BFF70-7090-4E5C-8EF5-A6A0A0E25E1EQ34105228-8DC51A1D-235E-44B9-B6BE-3620D63D16FFQ34152302-78A87B35-5D9C-494A-9114-3FC979A345C9Q34494709-510FFE36-D502-4D56-9F15-5A28AB9BA8B1Q34845804-CA792A70-2B65-4E1A-8114-4D9FB367DFE7Q35027405-F25AAA88-AE4A-46D5-8489-513EA68C9CC6Q35070041-C507A413-754F-45E5-B294-41756CB194BCQ38044386-1A670D40-BAE1-4412-9881-92C5ECA23BBAQ38065262-6AD9FA38-5F9F-4CBE-9C2B-CCE3CF59C16DQ38156613-93FF3E50-98EF-4C55-962B-1D621402133DQ38874908-DE21AD6B-6156-4016-8871-48861878BA4FQ39132850-3490E9DB-A60A-476D-9696-35A494211396Q39182944-7230A7F0-4DBD-45E3-8BF0-A069B40E1DB8Q39569994-BC5F8921-EB26-4185-884E-ED9ABF93D9D4Q39829844-87001C80-B369-4C87-8BE4-9604CB08F0DAQ40017823-DB721AA3-387E-4FD4-84C7-B37F3859E211Q40535859-FD64EE4B-9559-4F2E-8713-9D98BDDA4181Q42072317-5E566424-08F9-4BC7-9466-A0B5B2C7FA6FQ42695916-6107C8C8-B9B7-4C94-AEA1-607A137063B9Q43817769-53316B92-BA39-4D2A-85C2-E1FA0DB52428Q44412691-FD761243-0635-4478-8537-33EF84747DF2Q54579646-284672FF-0AEA-45F3-9D21-348C043115FFQ55282930-A8029B4F-A40A-43D1-9EDB-1282AD017C8F
P2860
Tumour necrosis factor-alpha (TNF-alpha) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Tumour necrosis factor-alpha ( ...... of leprosy reversal reactions.
@en
type
label
Tumour necrosis factor-alpha ( ...... of leprosy reversal reactions.
@en
prefLabel
Tumour necrosis factor-alpha ( ...... of leprosy reversal reactions.
@en
P2093
P1476
Tumour necrosis factor-alpha ( ...... of leprosy reversal reactions.
@en
P2093
D N Lockwood
M J Colston
P M Brickell
S Khanolkar-Young
S Vinayakumar
P304
P356
10.1111/J.1365-2249.1995.TB05532.X
P577
1995-02-01T00:00:00Z